Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 26 July

Grady Wulff
July 26, 2024

Morning Bell 26 July

Sam Kanaan
July 26, 2024

Morning Bell 25 July

Grady Wulff
July 25, 2024

Morning Bell 24 July

Grady Wulff
July 24, 2024

Morning Bell 23 July

Sam Kanaan
July 23, 2024

Morning Bell 22 July

Grady Wulff
July 22, 2024

Weekly Wrap 19 July

Grady Wulff
July 19, 2024

Morning Bell 19 July

Sam Kanaan
July 19, 2024

Morning Bell 18 July

Sam Kanaan
July 18, 2024

Morning Bell 17 July

Grady Wulff
July 17, 2024

Morning Bell 16 July

Grady Wulff
July 16, 2024

Morning Bell 15 July

Grady Wulff
July 15, 2024